136 related articles for article (PubMed ID: 36283464)
1. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules.
Lasolle H; Lopez J; Pattou F; Borson-Chazot F; Bardet S; Groussin L; Buffet C
Ann Endocrinol (Paris); 2022 Dec; 83(6):395-400. PubMed ID: 36283464
[TBL] [Abstract][Full Text] [Related]
2. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Recommendations in thyroid cytology: from technique to interpretation.
Decaussin-Petrucci M; Albarel F; Leteurtre E; Borson-Chazot F; Cochand Priollet B
Ann Endocrinol (Paris); 2022 Dec; 83(6):389-394. PubMed ID: 36283459
[TBL] [Abstract][Full Text] [Related]
3. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Thyroid nodules in children.
Coutant R; Lugat A; Mirallié É; Oliver-Petit I; Stoupa A; Drui D
Ann Endocrinol (Paris); 2022 Dec; 83(6):431-434. PubMed ID: 36283462
[TBL] [Abstract][Full Text] [Related]
4. SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Epidemiology and challenges in the management of thyroid nodules.
Borson-Chazot F; Borget I; Mathonnet M; Leenhardt L
Ann Endocrinol (Paris); 2022 Dec; 83(6):378-379. PubMed ID: 36283463
[TBL] [Abstract][Full Text] [Related]
5. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Follow-up: How and how long?
Leboulleux S; Lamartina L; Lecornet Sokol E; Menegaux F; Leenhardt L; Russ G
Ann Endocrinol (Paris); 2022 Dec; 83(6):407-414. PubMed ID: 36283461
[TBL] [Abstract][Full Text] [Related]
6. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Thyroid nodules and pregnancy.
Drui D; Briet C; Guerin C; Lugat A; Borson-Chazot F; Grunenwald S
Ann Endocrinol (Paris); 2022 Dec; 83(6):435-439. PubMed ID: 36270537
[TBL] [Abstract][Full Text] [Related]
7. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Introduction to the consensus.
Borson-Chazot F; Lussey-Lepoutre C; Pattou F;
Ann Endocrinol (Paris); 2022 Dec; 83(6):375-377. PubMed ID: 36283460
[TBL] [Abstract][Full Text] [Related]
8. SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithms.
Borson-Chazot F; Buffet C; Decaussin-Petrucci M; Cao CD; Drui D; Leboulleux S; Leenhardt L; Menegaux F; Pattou F; Lussey-Lepoutre C;
Ann Endocrinol (Paris); 2022 Dec; 83(6):440-453. PubMed ID: 36336101
[TBL] [Abstract][Full Text] [Related]
9. SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Surgical treatment.
Menegaux F; Baud G; Chereau N; Christou N; Deguelte S; Frey S; Guérin C; Marciniak C; Paladino NC; Brunaud L; Caiazzo R; Donatini G; Gaujoux S; Goudet P; Hartl D; Lifante JC; Mathonnet M; Mirallié E; Najah H; Sebag F; Trésallet C; Pattou F
Ann Endocrinol (Paris); 2022 Dec; 83(6):415-422. PubMed ID: 36309207
[TBL] [Abstract][Full Text] [Related]
10. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Initial work-up for thyroid nodules.
Do Cao C; Haissaguerre M; Lussey-Lepoutre C; Donatini G; Raverot V; Russ G
Ann Endocrinol (Paris); 2022 Dec; 83(6):380-388. PubMed ID: 36280193
[TBL] [Abstract][Full Text] [Related]
11. SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : What is the role of functional imaging and isotopic treatment?
Thuillier P; Benisvy D; Ansquer C; Corvilain B; Mirallié E; Taïeb D; Borson-Chazot F; Lussey-Lepoutre C
Ann Endocrinol (Paris); 2022 Dec; 83(6):401-406. PubMed ID: 36273578
[TBL] [Abstract][Full Text] [Related]
12. SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Thermal ablation.
Ben Hamou A; Ghanassia E; Muller A; Ladsous M; Paladino NC; Brunaud L; Leenhardt L; Russ G
Ann Endocrinol (Paris); 2022 Dec; 83(6):423-430. PubMed ID: 36306894
[TBL] [Abstract][Full Text] [Related]
13. [SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Interest and place of thyroid cytology].
Decaussin-Petrucci M; Cochand Priollet B; Leteurtre E; Albarel F; Borson-Chazot F
Ann Pathol; 2024 Feb; 44(1):20-29. PubMed ID: 38092572
[TBL] [Abstract][Full Text] [Related]
14. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.
Duick DS; Klopper JP; Diggans JC; Friedman L; Kennedy GC; Lanman RB; McIver B
Thyroid; 2012 Oct; 22(10):996-1001. PubMed ID: 22873825
[TBL] [Abstract][Full Text] [Related]
15. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
16. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance.
Hall EA; Hartzband P; VanderLaan PA; Nishino M
Cancer Cytopathol; 2023 May; 131(5):313-324. PubMed ID: 36792948
[TBL] [Abstract][Full Text] [Related]
18. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
[No Abstract] [Full Text] [Related]
19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.
Gharib H; Papini E; Garber JR; Duick DS; Harrell RM; Hegedüs L; Paschke R; Valcavi R; Vitti P;
Endocr Pract; 2016 May; 22(5):622-39. PubMed ID: 27167915
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic accuracy of fine-needle aspiration cytology for thyroid nodules is not affected by coexistent chronic autoimmune thyroiditis: results from a cyto-histological series of patients with indeterminate cytology.
Rotondi M; Molteni M; Cappelli C; Croce L; Caputo A; Groppelli G; Liboà F; Guazzoni V; Villani L; Zeppa P; Chiovato L
Eur J Endocrinol; 2021 Jun; 185(2):201-208. PubMed ID: 34048364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
